Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2

Abstract

The objective — ​to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2. Patients of the first group in addition to the basic treatment for DM received meldonium (Vazonat, OlainFarm JSC, Latvia) at a dose of 1000 mg/day during 12 weeks. The second group included 25 patients with DM type 2 (8 men and 17 women, average age 60.4 ± 1.9 years), who received only basic therapy of DM. Results. 12-week meldonium therapy as a part of combination therapy for DM type 2 statistically significantly improves the performance of kidney function, as indicated by a significant reduction in the level of microalbuminuria, creatinine and increased glomerular filtration rate in the first group of patients. Inclusion in the treatment regimen of Vazonat in patients with type 2 DM improves morphofunctional parameters of the heart, has additional nephroprotective action, reduces the average values of triglycerides and low-density lipoproteins, as well as glycated hemoglobin levels compared to baseline therapy. Conclusions. Vazonat, combining cardioprotective properties and hypoglycemic effect, is a particularly good choice for comprehensive treatment of patients with impaired glucose metabolism, diabetic nephropathy and heart failure.

Authors and Affiliations

V. I. Pankivn

Keywords

Related Articles

Vitamin D Deficiency and Insufficiency in Lviv Region Residents

Vitamin D is one of the important metabolites of the human body, which has a wide spectrum of effects and is a co-regulator of many important physiological processes. The aim of the study was to evaluate the incidence of...

Features of lymphocyte phenotyping in patients with activated recurrent herpetic infection of the first/second type and reproductive system disorders

The aim of the study was an analysis of the features of changes in lymphocyte subpopulation according to the data of immunography in patients with a recrudescent herpetic infection and reproductive violations. Materials...

Role of Foxo1 gene expression in mechanism of antihypertrophic action of metformin in cardiomyocytes

Background. Diabetic cardiomyopathy is the leading cause of mortality in patients with type 2 diabetes mellitus. Hypertrophy of cardiomyocytes is one of the main pathomorphological signs of diabetic cardiomyopathy develo...

Snps Gln27Glu Polymorphism of β2-Adrenoceptor Gene and Carbohydrate and Lipid Metabolism Impairment in Obese Patients with Ischemic Heart Disease

This article estimates the role of Gln27Glu polymorphism of β2-adrenergic receptors gene in forming violations of carbohydrate and lipid metabolism in obese patients with ischemic heart disease. A comprehensive survey of...

Treatment of Hypothyroidism according to Modern Clinical Guidelines

The most important aspects of hypothyroidism treatment in accordance with the latest international guidelines developed from evidence-based medicine are given in the article. Approaches to levothyroxine therapy in certai...

Download PDF file
  • EP ID EP201725
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

V. I. Pankivn (2016). Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2. Міжнародний ендокринологічний журнал, 4(76), 80-84. https://europub.co.uk/articles/-A-201725